Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer-Reference-Cited by-同舟云学术

Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer

Published:2019-03-10 Issue:5 Volume:69 Page:2048-2060
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Xie Changqing¹,Duffy Austin G.²,Mabry‐Hrones Donna²,Wood Bradford³,Levy Elliot³,Krishnasamy Venkatesh³,Khan Javed⁴,Wei Jun S.⁴,Agdashian David²,Tyagi Manoj⁴,Gangalapudi Vineela⁴,Fioravanti Suzanne²,Walker Melissa²,Anderson Victoria³,Venzon David⁵,Figg William D.⁶,Sandhu Milan²,Kleiner David E.⁷,Morelli Maria Pia¹,Floudas Charalampos S.¹,Brar Gagandeep¹,Steinberg Seth M.⁸,Korangy Firouzeh²,Greten Tim F.²⁹

Affiliation:

1. Hematology/Oncology Fellowship Program National Heart, Lung, and Blood Institute/National Cancer Institute, National Institutes of Health Bethesda MD

2. Gastrointestinal Malignancies Section, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda MD

3. Radiology and Imaging Sciences, Center for Cancer Research National Institutes of Health Bethesda MD

4. Genetics Branch, Center for Cancer Research NCI, NIH Bethesda MD

5. Biostatistics and Data Management Section NCI, NIH Bethesda MD

6. Clinical Pharmacology Program, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda MD

7. Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda MD

8. Biostatistics and Data Management Section, Center for Cancer Research National Institutes of Health Bethesda MD

9. NCI CCR Liver Cancer Program Bethesda MD

Funder

NCI

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30482

Reference29 articles.

1. New Horizons for Precision Medicine in Biliary Tract Cancers

2. Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer

3. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

4. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

5. Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergizing Thermal Ablation Modalities with Immunotherapy: Enough to Induce Systemic Antitumoral Immunity?;Journal of Vascular and Interventional Radiology;2024-02

2. Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma;Cancer Medicine;2024-01-11

3. More Ultrasound-Guided Percutaneous Microwave Ablation Leads to Higher Immune-Related Gene Expression and Boosts PD-1 Monoclonal Antibodies for Liver Cancer;Ultrasound in Medicine & Biology;2024-01

4. Emerging trends in gastrointestinal cancers: Targeting developmental pathways in carcinogenesis and tumor progression;International Review of Cell and Molecular Biology;2024

5. Identification of genes associated with gall bladder cell carcinogenesis: Implications in targeted therapy of gall bladder cancer;World Journal of Gastrointestinal Oncology;2023-12-15